Prof Bobby Gaspar, PhD, MRCP(UK), MRCPCH

Professor of Paediatrics and Immunology, UCL Institute of Child Health
Honorary Consultant in Paediatric Immunology, Great Ormond Street Hospital

Bobby Gaspar is a physician/scientist working in paediatric immunology at the Institute of Child Health (ICH) and Great Ormond Street London. He initially trained in paediatrics and then became interested in primary immunodeficiencies at an early stage in his career and undertook a PhD at the Molecular Immunology Unit at ICH. From there he has continued his academic and clinical career. His interests are in many different aspects of primary immunodeficiency including understanding the molecular and cellular defects and disease pathogenesis, bone marrow transplantation for severe immunodeficiencies and the development of gene and cell therapy for these conditions. Over the last decade, his team have conducted clinical trials that have shown that gene therapy can successfully correct the immune defect in specific immunodeficiency conditions. He is leading UK and European initiatives for newborn screening for severe combined immunodeficiency. He is also Director of the Centre for Research in Rare Diseases in Children (CRRDC) a new academic and clinical facility that will open at Great Ormond Street in 2018.

Chairman, Clinical Working Party of ESID 2004 – 2008
Chairman, ESID BMT and Gene therapy Working party 2008 – 2013
Chairman EBMT Inborn Errors Working party 2008 – 2013

Member, International Committee, American Society of Gene Therapy, 2008 – present day
Chair, IUIS PID – Expert committee 2013 – present day
Chair, International Committee, American Society of Gene Therapy, 2013 – present day
Deputy Editor – Molecular therapy 2013 onwards

Chairman, Medical Advisory Panel – International Patient Organisation for Primary Immunodeficiencies, 2013 onwards
Member, Medical Advisory Panel – PID-UK, 2013 onwards
Member, Medical Advisory Panel – Ataxia Telangiectasia Society, 2013 onwards